V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214893 | 20130122 | null | null | Palliative (P) | 2016-09-14 | 2016-10-24 | Trial Unspecified | 02 | N | OXALIPLATIN + RALTITREXED | 100347945 |
| 20214894 | 20130123 | 1.86 | 84.25 | Palliative (P) | 2017-08-25 | 2017-09-16 | EOX | 02 | null | EOX | 101488086 |
| 20214895 | 20130124 | 1.73 | 49 | Palliative (P) | 2018-01-30 | 2018-06-02 | EOX | 02 | Y | OXALIPLATIN + RALTITREXED | 101279291 |
| 20214896 | 20130125 | 1.43 | 99.8 | Palliative (P) | 2018-11-13 | 2018-12-11 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100471720 |
| 20214897 | 20130126 | 1.73 | 87.6 | null | 2019-03-08 | 2019-08-14 | EOX | 2 | null | EOX | 100016782 |
| 20214898 | 20130127 | 1.6 | 105.8 | Palliative (P) | 2017-09-23 | 2019-07-29 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100108905 |
| 20214900 | 20130128 | 1.69 | 61 | Palliative (P) | 2017-03-08 | 2017-03-27 | EOX | 02 | N | EOX | 100383056 |
| 20214901 | 20130129 | 1.75 | 73.2 | Palliative (P) | 2016-07-31 | 2016-08-15 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100939900 |
| 20214902 | 20130130 | 1.88 | 76.7 | Palliative (P) | 2018-08-07 | 2018-08-14 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100778382 |
| 20214903 | 20130131 | 1.74 | 51.2 | Palliative (P) | 2016-03-29 | 2016-08-19 | EOX | N | null | EOX | 100196777 |
| 20214907 | 20130132 | 1.61 | 72.4 | Palliative (P) | 2019-03-14 | 2019-03-17 | EOX | 02 | null | SORAFENIB | 100571351 |
| 20214909 | 20130133 | 1.62 | 107 | Palliative (P) | 2018-06-03 | 2018-06-10 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 100769305 |
| 20214910 | 20130134 | 1.67 | 72.2 | null | 2021-05-13 | 2021-07-18 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100687275 |
| 20214912 | 20130135 | 1.57 | 76 | Palliative (P) | 2017-04-02 | 2017-04-10 | EOX | 02 | N | CAPECITABINE + RT | 100294619 |
| 20214914 | 20130136 | 1.71 | 63 | Palliative (P) | 2019-08-14 | 2019-08-21 | EOX | 01 | N | CETUXIMAB + IRINOTECAN + MDG | 101577670 |
| 20214916 | 20130137 | 1.64 | 76.2 | Curative (C) | 2016-07-30 | 2016-09-15 | Sorafenib | 02 | Y | SORAFENIB | 101306939 |
| 20214919 | 20130138 | 1.63 | 77.2 | Neo-adjuvant (N) | 2019-11-16 | 2019-12-09 | EOX | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101227601 |
| 20214920 | 20130139 | 1.72 | 62.4 | Palliative (P) | 2016-04-17 | 2016-05-31 | EOX | 02 | N | CAPECITABINE + RT | 100742472 |
| 20214921 | 20130140 | 1.58 | 74 | Curative (C) | 2020-01-04 | 2020-01-17 | CAPECITABINE + RT | 99 | N | CAPECITABINE + RT | 101732550 |
| 20214922 | 20130141 | 1.81 | 80.75 | Palliative (P) | 2017-10-29 | 2017-10-30 | Oxaliplatin + Raltitrexed | N | N | OXALIPLATIN + RALTITREXED | 100183244 |
| 20214923 | 20130142 | 1.84 | 60.25 | Palliative (P) | 2020-11-16 | 2020-11-17 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100171302 |
| 20214925 | 20130143 | null | 43.5 | Palliative (P) | 2020-08-04 | 2020-08-04 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101420717 |
| 20214927 | 20130144 | 1.67 | 66.4 | Palliative (P) | 2016-05-30 | 2017-03-03 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101454050 |
| 20214929 | 20130145 | 1.74 | 60 | Palliative (P) | null | 2018-08-02 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100749383 |
| 20214931 | 20130146 | 1.78 | 95.4 | null | 2019-12-26 | 2020-01-16 | Sorafenib | 02 | null | SORAFENIB | 101796159 |
| 20214934 | 20130147 | 1.88 | 92.7 | null | 2019-11-14 | 2019-11-15 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100263636 |
| 20214939 | 20130148 | 1.75 | 74.7 | Adjuvant (A) | 2015-07-18 | 2019-05-29 | EOX | 02 | N | SORAFENIB | 101357472 |
| 20214940 | 20130149 | 1.74 | 80.5 | Curative (C) | 2016-10-27 | 2016-10-27 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100136660 |
| 20214942 | 20130150 | 1.84 | 76 | Palliative (P) | 2018-07-16 | 2019-03-05 | EOX | 02 | N | TRIAL | 101583772 |
| 20214944 | 20130151 | 1.72 | 63 | Palliative (P) | 2016-11-02 | 2019-05-14 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101257816 |
| 20214945 | 20130152 | 1.69 | 66.3 | Adjuvant (A) | 2016-07-28 | 2016-09-09 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101395902 |
| 20214946 | 20130153 | 1.82 | 57.5 | null | 2019-11-09 | 2019-11-25 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101338200 |
| 20214947 | 20130154 | null | 75.8 | Palliative (P) | 2016-06-25 | 2018-01-11 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101136537 |
| 20214948 | 20130155 | 1.52 | 56.1 | Palliative (P) | 2020-10-01 | 2020-10-08 | EOX | 02 | N | EOX | 100230408 |
| 20214950 | 20130156 | 1.6 | 59.8 | Palliative (P) | 2020-08-25 | 2020-08-25 | EOX | 02 | N | EOX | 100994276 |
| 20214952 | 20130157 | 1.85 | 91.7 | null | 2019-07-10 | 2019-07-19 | Capecitabine 35days + RT | 02 | null | CAPECITABINE + RT | 100014991 |
| 20214955 | 20130158 | 1.77 | 87.4 | Palliative (P) | 2017-07-09 | 2017-07-09 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | OXALIPLATIN + RALTITREXED | 101504337 |
| 20214956 | 20130159 | 1.63 | 74.4 | Palliative (P) | 2017-06-16 | 2017-06-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101417284 |
| 20214957 | 20130160 | 1.58 | 100.4 | Adjuvant (A) | 2019-01-27 | 2019-02-20 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100333603 |
| 20214959 | 20130161 | 1.69 | null | Neo-adjuvant (N) | 2019-08-12 | 2019-08-13 | EOX | 02 | N | EOX | 101358801 |
| 20214963 | 20130162 | 1.7 | 92 | Palliative (P) | 2020-03-02 | 2020-03-24 | EOX | 02 | N | EOX | 100828109 |
| 20214964 | 20130163 | 1.61 | 58.4 | null | 2019-05-15 | 2019-05-29 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101055371 |
| 20214965 | 20130164 | 1.63 | 59 | null | 2016-09-01 | 2016-09-08 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100505106 |
| 20214966 | 20130165 | 1.94 | 77.8 | null | 2020-01-26 | 2020-02-02 | EOX | 02 | null | SORAFENIB | 101333253 |
| 20214967 | 20130166 | 1.71 | 58 | Palliative (P) | 2018-08-22 | 2018-08-22 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100198881 |
| 20214968 | 20130167 | 1.64 | 108.4 | Palliative (P) | 2017-04-04 | 2017-04-06 | Sorafenib | 02 | N | SORAFENIB | 101058378 |
| 20214971 | 20130168 | 1.6 | 60.8 | Palliative (P) | 2021-02-07 | 2021-02-13 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101187335 |
| 20214972 | 20130169 | 1.82 | 76.2 | Adjuvant (A) | 2017-07-02 | 2017-07-04 | Trial Unspecified | Y | N | TRIAL | 101139540 |
| 20214976 | 20130170 | 1.6 | 46.2 | null | 2018-07-27 | 2018-09-22 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100942694 |
| 20214978 | 20130171 | 1.7 | 98 | Palliative (P) | 2017-09-10 | 2017-12-14 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100077899 |